TuHURA Biosciences, Inc.
HURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498382
No open-market purchases or sales by TuHURA Biosciences, Inc. insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding TuHURA Biosciences, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 9 | 10 | +1 |
| Shares | 41.0K | 72.3K | +31.3K (+76.4%) |
| Value | $164.0K | $291.1K | +$127.0K (+77.4%) |
New holders (3)
Institutions that held TuHURA Biosciences, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nantahala Capital Management, LLC | 22,619 | $91.4K | 0.01% |
| Vanguard Group Inc | 12,455 | $50.3K | 0.00% |
| Bank of America Corp | 200 | $808 | 0.00% |
Sold out (2)
Institutions that held TuHURA Biosciences, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| JPMorgan Chase & Co | 559 | $2.25K |
| UBS Group AG | 65 | $262 |